Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, Mantle-Cell 3Lymphoma, Non-Hodgkin 2Recurrence 1

Interventions

Rituximab 59Cyclophosphamide 35Vincristine 28Doxorubicin 24Prednisone 22Bendamustine Hydrochloride 17Etoposide 15Radiotherapy 12Cytarabine 10Peripheral Blood Stem Cell Transplantation 8Filgrastim 8ibrutinib 7VAP-cyclo protocol 7Prednisolone 7Methotrexate 7Granulocyte Colony-Stimulating Factor 7ibritumomab tiuxetan 6fludarabine 6Melphalan 6Gemcitabine 6pirtobrutinib 5Mitoxantrone 5Lenalidomide 5Carmustine 5Bleomycin 5pixantrone 4Mycophenolic Acid 4Methylprednisolone 4Ifosfamide 4Idarubicin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Non-Hodgkin × R-CHOP protocol × Clear all
NCT03650933 2024-02-20

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

Nanjing Yoko Biomedical Co., Ltd.

Phase 3 Unknown
360 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT00554164 2017-05-05

PETAL

University Hospital, Essen

Phase 3 Completed
1,073 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡